Sanjeev Phatak

Antibody response after first and second-dose of ChAdOx1-nCOV (CovishieldTM®) and BBV-152 (CovaxinTM®) among health care workers in India: The final results of cross-sectional coronavirus vaccine-induced antibody titre (COVAT) study

Awadhesh Kumar Singh, Sanjeev Phatak, Ritu Singh et al. · Vaccine · 2021 · 126 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +10

Improved Medication Adherence and Frequency of Blood Glucose Self-Testing Using an m-Health Platform Versus Usual Care in a Multisite Randomized Clinical Trial Among People with Type 2 Diabetes in India

Nora J. Kleinman, Avani Shah, Sanjiv J. Shah et al. · Telemedicine Journal and e-Health · 2017 · 113 citations

Humoral antibody kinetics with ChAdOx1-nCOV (Covishield™) and BBV-152 (Covaxin™) vaccine among Indian Healthcare workers: A 6-month longitudinal cross-sectional Coronavirus Vaccine-induced antibody titre (COVAT) study

Awadhesh Kumar Singh, Sanjeev Phatak, Ritu Singh et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 2022 · 37 citations · Full text

Vaccinology, Vaccine Safety, Vaccination +11

COVID-19 associated mucormycosis: A Descriptive Multisite Study from India

Ritesh Gupta, Jothydev Kesavadev, Gopika Krishnan et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 2021 · 21 citations · Full text

Covid-19 Associated Mucormycosis, Covid-19 Pandemic, Infection Control +3

Antibody Response after First-dose of ChAdOx1-nCOV (Covishield™ ^® ) and BBV-152 (Covaxin™ ^® ) amongst Health Care Workers in India: Preliminary Results of Cross-sectional Coronavirus Vaccine-induced Antibody Titre (COVAT) study

Awadhesh Kumar Singh, Sanjeev Phatak, Nagendra Kumar Singh et al. · 2021 · 18 citations · Full text